Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AXDXNASDAQ:TBIOOTCMKTS:TKOINASDAQ:TLIS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAXDXAccelerate Diagnostics$0.65$0.03▼$2.09$857K0.22521,768 shs53.64 million shsTBIOTelesis Bio$0.30+200.0%$0.20$0.01▼$6.17$541K0.966,759 shs2,028 shsTKOITelkonet$0.01+1.9%$0.01$0.00▼$0.01$1.53M-0.121,163 shs34,136 shsTLISTalis Biomedical$1.40-2.1%$1.51$1.04▼$9.35$2.55M1.32,690 shs480 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAXDXAccelerate Diagnostics0.00%0.00%0.00%-94.21%-96.54%TBIOTelesis Bio+200.00%+200.00%+53.37%+3.45%-92.25%TKOITelkonet+1.89%+8.00%-3.57%+92.86%-26.03%TLISTalis Biomedical-2.10%-20.00%-6.67%-19.54%-83.53%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAXDXAccelerate DiagnosticsN/AN/AN/AN/AN/AN/AN/AN/ATBIOTelesis BioN/AN/AN/AN/AN/AN/AN/AN/ATKOITelkonetN/AN/AN/AN/AN/AN/AN/AN/ATLISTalis Biomedical0.3282 of 5 stars0.02.00.00.00.02.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAXDXAccelerate Diagnostics 4.00Strong BuyN/AN/ATBIOTelesis Bio 0.00N/AN/AN/ATKOITelkonet 0.00N/AN/AN/ATLISTalis Biomedical 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAXDXAccelerate Diagnostics$11.70M0.00N/AN/A($1.37) per share0.00TBIOTelesis Bio$225.09M0.00N/AN/A$0.14 per share2.14TKOITelkonet$8.90M0.18N/AN/AN/A∞TLISTalis Biomedical$300K8.51N/AN/A$37.95 per share0.04Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAXDXAccelerate Diagnostics-$61.62M-$2.34N/AN/AN/A-471.83%N/A-191.66%N/ATBIOTelesis Bio-$47.72M-$28.20N/A∞N/A-336.59%N/A-61.89%8/5/2025 (Estimated)TKOITelkonet-$1.19MN/A0.00∞N/AN/AN/AN/AN/ATLISTalis Biomedical-$62.01M-$28.02N/A∞N/AN/A-79.74%-57.16%8/18/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAXDXAccelerate DiagnosticsN/AN/AN/AN/AN/ATBIOTelesis BioN/AN/AN/AN/AN/ATKOITelkonetN/AN/AN/AN/AN/ATLISTalis BiomedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAXDXAccelerate DiagnosticsN/A1.501.34TBIOTelesis BioN/A1.231.06TKOITelkonetN/AN/AN/ATLISTalis BiomedicalN/A7.767.76Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAXDXAccelerate Diagnostics17.14%TBIOTelesis Bio37.63%TKOITelkonetN/ATLISTalis Biomedical43.77%Insider OwnershipCompanyInsider OwnershipAXDXAccelerate Diagnostics43.60%TBIOTelesis Bio24.50%TKOITelkonet55.30%TLISTalis Biomedical46.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAXDXAccelerate Diagnostics22025.21 million14.13 millionOptionableTBIOTelesis Bio2001.80 million1.36 millionOptionableTKOITelkonet30288.66 million129.03 millionNot OptionableTLISTalis Biomedical2601.82 million984,000No DataTKOI, TLIS, AXDX, and TBIO HeadlinesRecent News About These CompaniesTalis Biomedical (NASDAQ:TLIS) Stock Price Down 18.3% - Here's What HappenedJune 26 at 2:59 AM | americanbankingnews.comBaker Bros. Advisors LP's Strategic Acquisition in Talis Biomedical CorpOctober 10, 2024 | finance.yahoo.comTalis Biomedical Agrees to Settle Investor Suit for $33 MillionOctober 3, 2024 | news.bloomberglaw.comNTalis Biomedical Corp Ordinary SharesSeptember 17, 2024 | morningstar.comMInsider Buying: Talis Biomedical Co. (NASDAQ:TLIS) Major Shareholder Buys 13,167 Shares of StockAugust 29, 2024 | insidertrades.comTalis Biomedical Shares Fall on Bankruptcy Filing, Delisting NoticeAugust 24, 2024 | marketwatch.comTLIS Stock Earnings: Talis Biomedical Reported Results for Q2 2024August 19, 2024 | investorplace.comTalis Biomedical Shares Tumble Premarket as Company Mulls BankruptcyAugust 7, 2024 | marketwatch.comWhy Talis Biomedical (TLIS) Stock Is Getting Obliterated TodayAugust 7, 2024 | benzinga.comWhy Is Talis Biomedical (TLIS) Stock Down 52% Today?August 7, 2024 | investorplace.com(TLIS) Trading ReportJuly 25, 2024 | news.stocktradersdaily.comNTalis Biomedical Corp (TLIS)May 10, 2024 | investing.comTLIS Stock Earnings: Talis Biomedical Reported Results for Q1 2024May 8, 2024 | investorplace.comBragar Eagel & Squire is Investigating Certain Officers and Directors of Talis, TaskUs, and ...April 27, 2024 | eagletribune.comETalis Biomedical Corporation (TLIS)March 31, 2024 | finance.yahoo.comGrabar Law Office Investigates Claims on Behalf of Shareholders of Talis Biomedical CorporationFebruary 16, 2024 | markets.businessinsider.comTLIS Feb 2024 2.500 putFebruary 15, 2024 | finance.yahoo.comPeninsula diagnostics company to close Redwood City labs and offices, pursue 'strategic alternatives'November 14, 2023 | bizjournals.comTalis Biomedical Corporation: Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve CashNovember 14, 2023 | finanznachrichten.deLICY, BTAI and HROW among mid-day moversNovember 14, 2023 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTKOI, TLIS, AXDX, and TBIO Company DescriptionsAccelerate Diagnostics NASDAQ:AXDX$0.04 +0.04 (+∞) As of 05/14/2025 This is a fair market value price provided by Polygon.io. Learn more.Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.Telesis Bio NASDAQ:TBIO$0.30 +0.20 (+200.00%) As of 06/27/2025 12:56 PM EasternTelesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. The company offers BioXp 3250 system and BioXp 9600 system that empower researchers to go from a digital DNA sequence to endpoint-ready synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) with onboard next generation sequencing (NGS) library preparation; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice, as well as mRNA constructs; and BioXp De Novo kits, which contains building blocks and reagents, including proprietary Gibson assembly branded reagents for specific synthetic biology workflow applications. It also provides BioXp Select kits that offers to use non-telesis bio DNA while using the BioXp system to perform synthetic biology workflow applications, such as cloning, mRNA generation from plasmid, and cell free amplification; BioXp Next Generation Sequencing kits, which contains reagents to go from DNA or RNA to a sequencer-ready library; Benchtop reagents that contains the reagents to proceed specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and custom Gibson short oligo ligation assembly enzymatic DNA synthesis solutions, which is designed to construct synthetic DNA, RNA, and proteins for development of mRNA-based vaccines, diagnostics, therapeutics, and personalized medicines. The company serves its products to government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as Codex DNA, Inc. and changed its name to Telesis Bio Inc. in November 2022. Telesis Bio, Inc. was incorporated in 2011 and is headquartered in San Diego, California.Telkonet OTCMKTS:TKOI$0.0054 +0.00 (+1.89%) As of 06/27/2025 02:46 PM EasternTelkonet, Inc. provides EcoSmart and Rhapsody platforms of intelligent automation solutions for the Internet of Things in the United States. Its platforms provide savings, management reporting, analytics, and virtual engineering of a customer's portfolio and/or property's room-by-room energy consumption. The company offers EcoSmart product suite, including EcoInput, a lighting controller installed directly in line with existing light switches; EcoTouch Thermostat, a touch capacitive thermostat interface; EcoInsight Thermostat, a programmable and controllable wired thermostat; EcoAir Thermostat, a wireless thermostat; EcoSource Controller, a remote HVAC control device; EcoSmart VRF controllers; EcoConnect Bridge, an Ethernet to Zigbee bridge; EcoCommander Gateway, a network-edge gateway server; EcoSense Occupancy Sensor, a remote occupancy sensor; EcoSwitch Light Switch, an energy management product; EcoGuard Outlet, an EcoSmart control; and EcoContact Door & Window Sensor, a remote wireless door/window contact solution. It also provides EcoCentral, a solution for intelligent automation and energy management; EcoCare professional support services; and Rhapsody Platform focuses on utilizing WIFI and Bluetooth Low Energy for mobile app-based setup and configuration. The company serves the hospitality, educational, governmental, healthcare, multiple dwelling units, and other commercial markets. Telkonet, Inc. was founded in 1977 and is headquartered in Waukesha, Wisconsin.Talis Biomedical NASDAQ:TLIS$1.40 -0.03 (-2.10%) As of 06/27/2025 10:23 AM EasternTalis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Addition by Subtraction: Intel’s New Strategy Energizes Investors NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside QuantumScape Soars 30%: What Drove the Next-Gen EV Stock's Rally Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
